Cytokine production in Ancylostoma duodenale infection.

Abstract

Cytokine response to Ancylostoma duodenale (A. duodenale) infection was measured after starting treatments with piperazine. This study aims to determine the impact of cytokine production after infection with A. duodenale before and after treatment with piperazine. Blood and stool samples of 50 patients with A. duodenale infection and 28 healthy individuals (control) were collected. In this study, IFNγ, IL-5, IL-12, and IL-13 in serum (using ELISA-based methods) were measured. Stool samples were examined using the Kato-Katz technique to detect A. duodenale parasites. Blood and stool samples were analyzed 14 days after starting piperazine treatment for A. duodenale infection. The medium concentration of IFNγ, IL-5, IL-12, and IL-13 in the serum samples with A. duodenale infection is higher than that of the control group. IFNγ, IL-5, IL-12, and IL-13 levels were significantly higher in the infected individuals (10.5±7.4 pg/ml, 14.6±5.1 pg/ml, 8.5±3.2 pg/ml and 13.6±7.5 pg/ml respectively) than the control group (4.7±2.4 pg/ml, 7.8±4.06 pg/ml, 6.3±3.4 pg/ml and 3.5±2.7 pg/ml respectively). Also, piperazine treatment can significantly reduce cytokines levels (IFN-γ: P=0.043, IL-5: P=0.02, and IL-12, p=0.001). This study shows that piperazine treatment can reduce cytokines profiles in patients with A. duodenale infection.

• Authors: Shaimaa Abdulhussein Shlash, Zubaida Falih Alzubaidi, Huda Ali Saleh
• Journal: Journal of medicine and life (J Med Life) Vol. 15 Issue 4 Pg. 479-482 (Apr 2022) ISSN: 1844-3117 [Electronic] Romania
• PMID: 35646178 (Publication Type: Journal Article)
• Copyright: ©2022 JOURNAL of MEDICINE and LIFE.

Chemical References

• Cytokines
• Interleukin-13
• Interleukin-5
• Piperazines
• Interleukin-12

Topics

• Ancylostomiasis (drug therapy, immunology)
• Cytokines (immunology)
• Humans
• Interleukin-12
• Interleukin-13
• Interleukin-5
• Piperazines (therapeutic use)